Node,Category
AKT1,Gene
BRAF,Gene
CCND1,Gene
CCNE1,Gene
CDKN1A,Gene
CDKN2A,Gene
CDKN2B,Gene
E2F1,Gene
EGFR,Gene
ERBB2,Gene
ESR1,Gene
MDM2,Gene
MTOR,Gene
MYC,Gene
NF1,Gene
NRAS,Gene
PIK3CA,Gene
PTEN,Gene
RB1,Gene
TP53,Gene
"MCF7, T47D",Cell type
Melanoma cells,Cell type
Braf(V600E) melanoma cells,Cell type
Melanoma cell lines,Cell type
Neuroblasts,Cell type
intestinal epithelial cells,Cell type
HEK293T cells,Cell type
Circulating tumor cells (CTCs),Cell type
Neuronal cells,Cell type
Neuroblastoma cells,Cell type
MSCs,Cell type
Tumor cells,Cell type
Glioma cells,Cell type
HaCaT cells,Cell type
Mucosal melanoma,Cell type
Testicular cells,Cell type
A549 cells,Cell type
TE-1 cells,Cell type
Chicken PGCs,Cell type
Myeloma cells,Cell type
"MCF-7, MDA-MB-231",Cell type
Placental explants,Cell type
HGC-27 cells,Cell type
Epidermal stem cells,Cell type
Breast cancer cell lines,Cell type
"OVCAR-3, Caov-4",Cell type
Myoblasts,Cell type
OSCC cells,Cell type
breast cancer cells,Cell type
Mesenchymal stem cells,Cell type
"OVCAR-3, Caov-4 cell lines",Cell type
Cancer cells,Cell type
Ovarian cancer cells,Cell type
"COS cells, osteoprogenitor C3H10T1/2 cells, chondrogenic RCJ3.1C5.18 cells",Cell type
"COS cells, RCJ3.1C5.18 cells",Cell type
Mammalian cells,Cell type
RB pathway,Cell type
MGC-803 cells,Cell type
B cells,Cell type
multiciliated cells,Cell type
MEFs,Cell type
PDCs,Cell type
Proliferating cells,Cell type
Fibroblasts,Cell type
"Cyclin D-CDK4,CDK6",Cell type
Cyclin D1,Cell type
Leiomyosarcomatous cells,Cell type
Rhabdomyosarcomatous cells,Cell type
Astrocytes,Cell type
MCF-7 cells,Cell type
Cell lines,Cell type
CMT cells,Cell type
Carcinoma cells,Cell type
Primary human melanocytes,Cell type
B-cell precursors,Cell type
Glioma cell lines,Cell type
T cells,Cell type
keratinocytes,Cell type
ECFCs,Cell type
NIH3T3 fibroblasts,Cell type
Cervical cancer cell lines,Cell type
Primary cells,Cell type
HCC cells,Cell type
Gallbladder cells,Cell type
Mouse MEL erythroleukemia cells,Cell type
Urothelial cells,Cell type
retinoblastoma,Cell type
HAOSMCs,Cell type
Cyclin D-dependent kinases,Cell type
granulocyte-monocyte precursors,Cell type
CD34+ progenitors,Cell type
Beta cells,Cell type
Autophagy regulators,Cell type
GBM cells,Cell type
Glioblastoma cells,Cell type
Chordoma cells,Cell type
RB-deficient cells,Cell type
Luminal A BC cells,Cell type
MCF7,Cell type
"Breast cancer cell lines, PDX models",Cell type
MCF-7 breast cancer cells,Cell type
hMSCs,Cell type
Lymphoid cells,Cell type
stromal cells,Cell type
"PDX models, PDCs",Cell type
PDX mouse models,Cell type
p53(wild-type),Cell type
MDA-MB-231 cells,Cell type
PI3K/AKT/mTOR pathway,Cell type
Primary GBM cell lines,Cell type
Circulating tumor cells,Cell type
B-cells,Cell type
NB cell lines,Cell type
AML cells,Cell type
non-IBC cells,Cell type
HPV(neg) HNSCC cell lines,Cell type
MCF7 cells,Cell type
Breast cancer cells,Cell type
pituitary cells,Cell type
Endothelial cells,Cell type
"P114,CF41 cells",Cell type
Mouse embryo fibroblasts,Cell type
CD34+ cells,Cell type
T-ALL cell line,Cell type
MCF-7,Cell type
TNBC cell lines,Cell type
pRb-competent cells,Cell type
Pituitary gland,Cell type
IBC cells,Cell type
Seminal vesicle tumors,Disease
Breast cancer,Disease
Gliosarcoma,Disease
"Gliosarcoma, glioblastoma",Disease
Glial cell transformation,Disease
Lung cancer,Disease
Melanoma,Disease
Prostate tumor,Disease
eGBM,Disease
Malignant melanoma,Disease
Acral melanocytic nevus,Disease
Acral melanoma,Disease
"Primary tumor, Secondary lesions",Disease
IDH-wildtype glioblastoma,Disease
Cancer,Disease
Nasal mixed exocrine-neuroendocrine carcinoma,Disease
Brain tumors,Disease
Solid tumors,Disease
Metastatic melanoma,Disease
papillary thyroid carcinoma,Disease
thyroid tumor,Disease
cancer,Disease
Glioblastoma,Disease
Low-grade serous ovarian cancer (LGSC),Disease
AM,Disease
HCC,Disease
Cutaneous melanoma,Disease
histiocytic sarcoma,Disease
Acral melanomas,Disease
Tumors,Disease
Colorectal cancer,Disease
"Melanoma, Cancer",Disease
Melanocytic tumors,Disease
PMM,Disease
Mucosal melanomas,Disease
Carcinomas,Disease
Tumor recurrence,Disease
Neuroblastic tumors,Disease
"Gliomas, Sarcomas, Melanoma, Breast cancer, Colorectal cancer",Disease
Anaplasia,Disease
Ganglioneuroma,Disease
Cervical carcinoma,Disease
Adenoma,Disease
Neoplasms,Disease
"Lymph node metastasis, depth of invasion",Disease
Adenocarcinomas,Disease
Esophageal conditions,Disease
Acral melanoma (AM),Disease
High-grade astrocytomas,Disease
Gallbladder cancer,Disease
"Glioblastoma, Brain metastases",Disease
MCL,Disease
Antiandrogen-resistant disease,Disease
Colorectal cancer (CRC),Disease
Cervical cancer,Disease
Immune-refractory cancer,Disease
Hepatocellular carcinoma (HCC),Disease
"Breast cancer, cancer",Disease
Retinoblastoma,Disease
Glioma,Disease
OSCC,Disease
Intestinal neoplasia,Disease
Intestinal adenomas,Disease
Intestinal carcinogenesis,Disease
Varicocele,Disease
Mammary carcinoma,Disease
Adenocarcinoma,Disease
diabetes,Disease
Head and neck squamous cell carcinoma (HNSCC),Disease
Tumor,Disease
Esophageal cancer,Disease
Malignant astrocytomas,Disease
GBM,Disease
Human cancers,Disease
Prostate cancer,Disease
Nasopharyngeal carcinoma (NPC),Disease
Myeloma,Disease
Mammary gland tumors,Disease
Ovarian cancer,Disease
Gastric carcinoma,Disease
Endocrine therapy-resistant breast cancer,Disease
Hepatocarcinogenesis,Disease
Liver tumors,Disease
Parathyroid tumors,Disease
Esophageal squamous cell carcinoma,Disease
Hepatocellular carcinoma,Disease
Skin tumors,Disease
"WDLPS,DDLPS",Disease
ER+ breast cancer,Disease
Endometrial carcinomas,Disease
Endometrioid-type endometrial carcinomas,Disease
NPC,Disease
Metastatic NPC,Disease
Oral squamous cell carcinoma,Disease
Therapy-refractory solid malignancies,Disease
Synovial sarcoma,Disease
HPV(U) tumors,Disease
Mantle cell NHL,Disease
Gastric cancer,Disease
Advanced gastric cancer,Disease
Parathyroid adenomas,Disease
Multiple myeloma,Disease
FAP (Familial Adenomatous Polyposis),Disease
Pancreatic ductal adenocarcinoma,Disease
Mantle cell lymphoma,Disease
Canine mammary gland cancer,Disease
SPA,Disease
Thin melanoma,Disease
"ESCC, esophageal dysplasia",Disease
HNSCC,Disease
Nonbreast solid tumors,Disease
Salivary gland tumors,Disease
HR-positive breast cancer,Disease
ALM,Disease
Multiple cancers,Disease
Nasopharyngeal carcinoma,Disease
Sarcomas,Disease
"breast cancer,head and neck cancer,non-small-cell lung cancer,mantle cell lymphomas",Disease
Advanced sarcomas,Disease
Skin cancer,Disease
HUC senescence,Disease
B cell non-Hodgkin's lymphoma (B-NHL),Disease
Extramammary Paget's disease (EMPD),Disease
FPA,Disease
Oral cancer,Disease
Soft tissue metastasis,Disease
Pleural mesothelioma,Disease
Thick melanoma,Disease
Glioblastomas,Disease
"Melanomas,Digestive cancers",Disease
"ALL, CML, ATL",Disease
ALL,Disease
Ovarian tumor,Disease
Uterine myosarcoma,Disease
Uterine leiomyosarcoma,Disease
Hereditary cutaneous melanoma,Disease
Human tumors,Disease
Sarcoma,Disease
"Melanoma, multiple cancers",Disease
Familial cutaneous malignant melanoma,Disease
"Melanoma,Neural system tumors",Disease
Hibernoma-like areas,Disease
Primary cutaneous melanoma (PCM),Disease
Amelanotic melanoma,Disease
Familial malignant melanoma,Disease
Familial melanoma,Disease
"Familial melanoma, multiple melanoma",Disease
Low-grade gliomas,Disease
Astrocytomas,Disease
"High-grade astrocytomas, glioma",Disease
"Astrocytomas, glioma",Disease
Uveal melanoma,Disease
Leukemia,Disease
Pediatric ALL,Disease
Head and neck cancer,Disease
"Astrocytic tumor, Oligodendroglial tumor",Disease
Metastases to pelvis and spine,Disease
Primary tumor,Disease
Cancer predisposition syndrome,Disease
"Malignant mesothelioma, Other cancers",Disease
Malignant mesothelioma,Disease
"Glioblastoma, low-grade astrocytoma, anaplastic astrocytoma",Disease
Lymphoid tumors,Disease
Mucosal melanoma,Disease
Oligodendroglioma,Disease
Anaplastic oligodendroglioma,Disease
WHO grade II oligodendroglioma,Disease
Barrett's adenocarcinomas,Disease
"Melanoma, tumors",Disease
Hereditary melanoma,Disease
Osteosarcoma,Disease
Melanocytic neoplasms,Disease
Lower grade astrocytomas,Disease
Dermatofibrosarcoma protuberans,Disease
Fibrosarcomatous DFSP,Disease
Ependymoma,Disease
FGFR-altered IGs,Disease
Cholangiocarcinoma,Disease
Serous ovarian tumor,Disease
"Melanoma, GBM",Disease
Non-small cell lung cancer (NSCLC),Disease
PDAC,Disease
Lung adenocarcinoma,Disease
PM,Disease
Ewing's sarcoma,Disease
Malignancies,Disease
BRAF inhibitor-resistant tumor,Disease
tumor,Disease
BCC,Disease
MHPC,Disease
Familial human melanoma,Disease
"Atherosclerosis, Type 2 diabetes mellitus (T2DM)",Disease
"T2DM, T2DM-CAD",Disease
"Familial melanoma, Sporadic melanoma",Disease
Non-small cell lung cancer,Disease
Cutaneous malignant melanoma,Disease
Esophageal carcinoma,Disease
"Retinoblastoma, Osteosarcoma",Disease
"gliomas, cancers",Disease
MPM,Disease
"Diffuse cerebral glioma, pleomorphic xanthoastrocytoma",Disease
Diffuse astrocytic glioma,Disease
Pleomorphic xanthoastrocytoma,Disease
"Pleomorphic xanthoastrocytoma, diffuse astrocytic glioma, oligodendroglial glioma",Disease
HPV-positive carcinoma,Disease
MPNST,Disease
Bladder tumors,Disease
Human tumor cell lines,Disease
Pituitary adenomas,Disease
Tumours,Disease
Pituitary tumours,Disease
"Leukemia, many cancers",Disease
Meningeal hemangiopericytomas,Disease
Chordoma,Disease
T2DM-CAD,Disease
"Atherosclerosis, T2DM",Disease
T2DM,Disease
Squamous cell carcinoma,Disease
T-cell acute lymphoblastic leukemia,Disease
"Human cancers, malignant melanoma",Disease
ESOS,Disease
"Pancreatic cancer, melanoma",Disease
"ALL T, ATL, CML",Disease
"Lung cancer, Colon cancer",Disease
"Neurofibromas, malignant peripheral nerve sheath tumors",Disease
"Skin cancer, SCCs, BCCs",Disease
Carcinogenesis,Disease
Moyamoya disease (MMD),Disease
"Familial melanoma, Tumours",Disease
Ovarian tumors,Disease
"Anaplastic astrocytomas, GBMs",Disease
ESCC,Disease
NSCLC,Disease
Non-small cell lung carcinoma,Disease
Head and neck squamous cell carcinoma,Disease
Leptomeningeal metastases of lung adenocarcinoma,Disease
Diffuse high-grade glioma (DHG),Disease
"Tumor, normal skin tissue",Disease
Plasmacytoma,Disease
Various tumor types,Disease
"Melanoma, Pancreatic cancer",Disease
"Liposarcoma, lipoma, liponecrosis",Disease
Liposarcoma,Disease
Basal cell carcinoma,Disease
Prostate carcinoma,Disease
Oligodendrogliomas,Disease
Head and neck tumors,Disease
"Liposarcoma, Lipoma",Disease
"sPNET, GBM",Disease
Hematopoietic malignancies,Disease
BTC,Disease
MHPCs,Disease
"Primary lesion, Metastatic lesion",Disease
Multiple cancer types,Disease
Acquired resistance,Disease
"GBM, GS",Disease
Glioblastoma multiforme (GBM),Disease
Penile squamous cell carcinoma,Disease
PMA,Disease
Metaplastic breast carcinoma,Disease
Hepatoid adenocarcinoma of the stomach (HAS),Disease
Disease progression,Disease
NAC-resistant tumors,Disease
NPC (nasopharyngeal carcinoma),Disease
Squamous cell lung cancer,Disease
EGFR-amplified tumours,Disease
Amplified tumors,Disease
Lung adenocarcinoma (LUAD),Disease
Advanced non-small cell lung cancer (NSCLC),Disease
Brain cancer,Disease
Pituitary neuroendocrine tumors (PitNET),Disease
Epithelial cancers,Disease
PeSCCA,Disease
Desmoplastic small round cell tumor (DSRCT),Disease
Lung metastases (LM),Disease
Metastatic breast cancer (mBC),Disease
METex 14 alteration,Disease
Lung metastases,Disease
Metastatic breast cancer,Disease
HER2-positive breast cancer,Disease
"ER-positive, HER2-negative breast cancer",Disease
Triple negative breast cancer,Disease
Endocrine resistance,Disease
"Hormone receptor-positive, HER2-negative breast cancer",Disease
Advanced breast cancer,Disease
metastatic breast cancer,Disease
Disease,Disease
Metastatic extramammary Paget's disease,Disease
Advanced-stage breast cancer,Disease
HER2-low tumors,Disease
Advanced/metastatic breast cancer,Disease
HR+/HER2+ metastatic breast cancer,Disease
Metastatic HR+/HER2- breast cancer,Disease
Early breast cancer,Disease
Metastatic breast cancer (MBC),Disease
HER2-low breast cancer,Disease
HER2+ advanced breast cancer,Disease
HER2-positive advanced breast cancer,Disease
HER2-positive/HR-positive advanced breast cancer,Disease
Cancers,Disease
Triple-negative breast cancer,Disease
Stage III and IV tumors,Disease
Estrogen receptor-positive metastatic breast cancer,Disease
ER-positive breast cancer,Disease
ER+ xenografts,Disease
ER+/RB-deficient xenografts,Disease
"Advanced estrogen receptor-positive, HER2-negative breast cancer",Disease
Peritoneal metastasis,Disease
"Breast cancer, gastric cancer with bone metastasis",Disease
ER伪+ breast cancer,Disease
breast cancer,Disease
tumors,Disease
HR+/HER2- metastatic breast cancer,Disease
Metastatic ER+ breast cancer,Disease
HR+ metastatic breast cancer,Disease
luminal androgen receptor (LAR) breast cancer,Disease
Metastatic disease,Disease
Endocrine therapy-resistant ESR1(+) breast cancer,Disease
"ER-positive, HER2-negative metastatic breast cancer",Disease
"ER-positive, HER2-positive breast cancer",Disease
ERα-positive breast cancer,Disease
Resistant tumors,Disease
Advanced cancers,Disease
Estrogen receptor-positive breast tumors,Disease
Estrogen receptor-positive breast cancer,Disease
Estrogen-accelerating PDX,Disease
Breast tumors,Disease
"Well-differentiated liposarcoma, Dedifferentiated liposarcoma",Disease
Liposarcomas,Disease
"Adipocytic tumors, atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDL)",Disease
"ALT/WDL, DDL",Disease
Dedifferentiated liposarcoma,Disease
Lipomatous tumor,Disease
DDLPS,Disease
"ALT/WDL, DDLPS",Disease
Low-grade central osteosarcoma,Disease
"Osteosarcoma, Liposarcoma",Disease
ALT,Disease
MPLPS,Disease
DLOS,Disease
Neoplastic tissue,Disease
"Atypical lipomatous tumor, Well-differentiated liposarcoma",Disease
"WDLPS, DDLPS",Disease
Rhabdomyosarcoma,Disease
Salivary gland tumor,Disease
"Lung adenocarcinoma, liposarcoma",Disease
Fatty tumors,Disease
Well-differentiated and dedifferentiated liposarcomas,Disease
Malignant gliomas,Disease
Alveolar subtype,Disease
"Well-differentiated liposarcomas, Dedifferentiated liposarcomas",Disease
Malignant fibrous histiocytoma,Disease
Neuroblastoma,Disease
Sclerosing liposarcoma,Disease
Pleural tumor,Disease
"Spindle cell lipoma, pleomorphic lipoma",Disease
Lipoma,Disease
ARMS,Disease
ERMS,Disease
RP sarcoma,Disease
Soft tissue sarcoma,Disease
Sarcomatoid CRCC,Disease
Uterine Adenosarcomas,Disease
"Liposarcoma (WDLPS, DDLPS)",Disease
Liposarcomatous differentiation,Disease
GBM (glioblastoma),Disease
Parosteal osteosarcoma,Disease
Intimal sarcoma,Disease
Atypical spindle cell/pleomorphic lipomatous tumor,Disease
IS,Disease
Undifferentiated sarcoma,Disease
ALT/WDL,Disease
Benign lipomatous lesions,Disease
"UHGPS,DDL",Disease
Malignant lipomatous tumors,Disease
UHGPS,Disease
"Lipoma, ALT/WDL",Disease
"Retroperitoneal pleomorphic MFH, dedifferentiated liposarcoma",Disease
Inflammatory MFH,Disease
POS,Disease
"Atypical lipomatous tumor, well-differentiated liposarcoma, dedifferentiated liposarcoma",Disease
"Soft tissue sarcomas, leiomyosarcomas (LMS), alveolar rhabdomyosarcomas (ARMS), embryonal rhabdomyosarcomas (ERMS)",Disease
UPSC sarcomas,Disease
Primary lesion,Disease
Soft tissue sarcomas,Disease
Mesenchymal tumors,Disease
APLT,Disease
Dedifferentiated osteosarcoma,Disease
"WDLS, DDLS",Disease
Well-differentiated spindle cell liposarcoma,Disease
"WDL,DDL",Disease
"UHGPS, DDLS",Disease
Inflammatory myofibroblastic tumor,Disease
p-SCs,Disease
Lipomatous neoplasms,Disease
Atypical lipomatous tumor,Disease
"Follicle center lymphomas, extranodal marginal zone lymphomas, mantle cell lymphomas",Disease
PCNSL,Disease
Anaplastic oligodendrogliomas,Disease
Glioblastoma (GB),Disease
Triple negative cancer,Disease
Luminal A cancer,Disease
Bone tumor,Disease
"ALT, parosteal osteosarcoma",Disease
"DDLPS,PLPS",Disease
Ossifying fibroma (OF),Disease
Juvenile ossifying fibroma (JOF),Disease
Malignant peripheral nerve sheath tumors,Disease
"HR+, HER2- breast cancer",Disease
Resistance in hormone-receptor-positive breast cancer,Disease
HR+/HER2- breast cancer,Disease
Advanced ER+ breast cancer,Disease
Endocrine-resistant breast cancer,Disease
PEComa,Disease
Myeloproliferative neoplasms (MPN),Disease
Neuroendocrine tumors (NETs),Disease
Hormone-resistant tumors,Disease
Non-clear cell RCC,Disease
ICC,Disease
Recurrent glioblastoma,Disease
Luminal ABC,Disease
"Dedifferentiated liposarcoma (DDL), leiomyosarcoma (LMS)",Disease
Recurrent tumors,Disease
Hormone receptor-positive (HR+) breast cancer,Disease
ER(+)/FGFR1(+) metastatic breast cancer,Disease
ER+ metastatic breast cancer,Disease
HR+ ABC,Disease
"Oral cancer, OSCC",Disease
Gynecologic cancers,Disease
"Breast cancer,RAS-mutant cancers",Disease
Metastatic colorectal cancer,Disease
Lymphoproliferative disorder (LPD),Disease
Pediatric medulloblastoma (MB),Disease
Adult tumors,Disease
Polycystic kidney disease,Disease
Medulloblastoma (Group3/4),Disease
Burkitt lymphoma,Disease
Triple-negative breast cancer (TNBC),Disease
BRCA(mut)/TNBC,Disease
Malignant peripheral nerve sheath tumors (MPNSTs),Disease
CA-Para,Disease
CA-Pheo,Disease
NF1-associated PNF,Disease
Liposarcoma (LPS),Disease
Acute Myeloid Leukemia (AML),Disease
NRAS-mutant melanoma,Disease
EAs,Disease
Non-invasive follicular thyroid neoplasm,Disease
CA,Disease
AML,Disease
PIK3CA-mutated advanced breast cancer,Disease
Metastasis,Disease
Diabetes,Disease
Lung squamous cell carcinoma (LUSC),Disease
HER2-negative/HR-positive breast cancer,Disease
non-IBC,Disease
HPV(neg) HNSCC,Disease
NRAS melanoma,Disease
PFS,Disease
High-grade astrocytic tumors,Disease
MBC,Disease
Mesothelioma,Disease
Multiple myeloma (MM),Disease
Metastases,Disease
Glioblastoma (GBM),Disease
HHT,Disease
Rb-deficient tumors,Disease
ER(+) breast cancer,Disease
"Estrogen receptor-positive, HER2-positive breast cancer",Disease
CRPC,Disease
Diet-induced obesity (DIO),Disease
TNBC,Disease
Atypical meningiomas,Disease
Liver tumor,Disease
Canine mammary carcinoma,Disease
osteosarcoma,Disease
Squamous Cell Carcinomas,Disease
Spindle cell lipoma,Disease
Childhood retinoblastoma,Disease
Bilateral retinoblastoma,Disease
"Breast cancer, melanoma, leukemia, lymphoma",Disease
RB1-deficient tumors,Disease
HR+ breast cancer,Disease
cancers,Disease
PV,Disease
SCLC,Disease
Endocrine therapy resistance,Disease
Thymic lymphomas,Disease
B-cell neoplasms,Disease
DPedHGG,Disease
Medulloblastoma,Disease
"GBM, sPNET",Disease
Colon Cancer,Disease
IBC,Disease
Senescence,Disease
Li-Fraumeni syndrome,Disease
Marginal zone lymphoma/Splenic B-cell lymphoma,Disease
High-grade glioma,Disease
Palbociclib,Drugs
SBX,Drugs
PL,Drugs
Notopterol,Drugs
Capivasertib,Drugs
"Capivasertib, anti-HER2 agents, endocrine treatment",Drugs
"Cobimetinib, ALK inhibitors",Drugs
"MEK inhibitors, CDK4/6 inhibitors",Drugs
"CDK4/6 inhibitors, BRAF/MEK-targeting agents",Drugs
"CDK4/6 inhibitors, BRAF inhibitors, MEK inhibitors",Drugs
"BRAF inhibitors, MEK inhibitors, CDK4/6 inhibitors",Drugs
CDK4/6 inhibitors,Drugs
Vemurafenib,Drugs
GLS1i,Drugs
anti-PD-1,Drugs
vemurafenib,Drugs
Tyrosine kinase inhibitors,Drugs
BRAF inhibitors,Drugs
"Trametinib, BKM120, LEE011",Drugs
"Palbociclib,BRAF inhibitors,MEK inhibitors",Drugs
"Encorafenib, Cetuximab, CDK4/6 inhibitors",Drugs
MEK inhibitors,Drugs
"Trametinib, Dabrafenib",Drugs
"Pembrolizumab, Durvalumab, Atezolizumab, BRAF inhibitors, MEK inhibitors",Drugs
"mTOR inhibitors, BRAF inhibitors, MEK inhibitors",Drugs
"BRAF inhibitors, MEK inhibitors",Drugs
NMBA,Drugs
"Abemaciclib, Ribociclib, Lenvatinib",Drugs
"letrozole, everolimus, palbociclib",Drugs
GRN163L,Drugs
"Palbociclib,Abemaciclib",Drugs
ZEN-3694,Drugs
LEE011,Drugs
Alcohol,Drugs
Mannoprotein,Drugs
PI3K/mTOR inhibitors,Drugs
Quercetin,Drugs
Bortezomib (BTZ),Drugs
SB431542,Drugs
PD-0332991,Drugs
3-carene,Drugs
Erufosine,Drugs
LPS,Drugs
Luteoloside,Drugs
"CTL, ERA",Drugs
BZD,Drugs
"berberine, evodiamine",Drugs
MCA,Drugs
EGCG,Drugs
HLCA,Drugs
Resveratrol,Drugs
"Vitamin K2, Vitamin K3",Drugs
GAA,Drugs
Artemisinin,Drugs
Smurf2 siRNA,Drugs
SAHA,Drugs
Rosiglitazone,Drugs
EESB,Drugs
AST,Drugs
9za,Drugs
"cis-nerolidol,trans-nerolidol",Drugs
Butein,Drugs
Salidroside,Drugs
IB-MECA,Drugs
PFE,Drugs
Metformin,Drugs
Abemaciclib,Drugs
"ERBB2 inhibitors, EGFR inhibitors",Drugs
BBR,Drugs
AB680,Drugs
PS1,Drugs
SRJ23,Drugs
Geldanamycin,Drugs
"Flavopiridol,Doxorubicin",Drugs
"Ceritinib, Ribociclib",Drugs
TMOC,Drugs
Rapamycin,Drugs
elacestrant,Drugs
"Abemaciclib, lenvatinib",Drugs
Propionate,Drugs
Talazoparib,Drugs
Endosulfan,Drugs
KT,Drugs
Enzalutamide,Drugs
PARP inhibitors,Drugs
Imatinib,Drugs
"palbociclib, trametinib",Drugs
"Palbociclib, Letrozole",Drugs
"MDM2/4 inhibitors, CDK4/6 inhibitors, immunotherapy",Drugs
palbociclib,Drugs
Combined drugs,Drugs
Doxorubicin,Drugs
ATRA,Drugs
"Osimertinib, Palbociclib",Drugs
"Osimertinib, palbociclib",Drugs
"palbociclib,celecoxib",Drugs
"CDK4/6 inhibitors, immunotherapy",Drugs
"Palbociclib, Cetuximab",Drugs
5-aza-2'-deoxycytidine,Drugs
PD0332991,Drugs
BRAF/MEK inhibitors,Drugs
DBF,Drugs
"Erk1/2 inhibitors,CDK4/6 inhibitors",Drugs
Osimertinib,Drugs
EGFR and HER2 inhibitors,Drugs
"EGFR blockers, CDK4/6 inhibitors",Drugs
"Cetuximab, Afatinib, Palbociclib",Drugs
"palbociclib, erlotinib",Drugs
EGFR-TKIs,Drugs
"Necitumumab, afatinib, erlotinib",Drugs
"MEK inhibitors, EGFR inhibitors",Drugs
"CDK4/6 inhibitors, EGFR inhibitors",Drugs
EGFR-TKI,Drugs
"Anti-EGFR therapy,CDK4/6 inhibitors",Drugs
"Temozolomide, CDK4/6 inhibitors, EGFR inhibitors",Drugs
PD 0332991,Drugs
EGFR inhibitors,Drugs
"Palbociclib,Erlotinib",Drugs
B7-H3,Drugs
"EGFR inhibitors, HER2 inhibitors",Drugs
"Afatinib,Palbociclib",Drugs
multi-kinase inhibitors,Drugs
Neoadjuvant therapy,Drugs
"Palbociclib, Fulvestrant",Drugs
"Fulvestrant, Capivasertib",Drugs
Trastuzumab,Drugs
"Abemaciclib, fulvestrant, palbociclib, ribociclib",Drugs
"HER2-directed therapy, Chemotherapy",Drugs
CDK4/6 inhibitor,Drugs
"ribociclib,palbociclib,abemaciclib",Drugs
"Neratinib,Trastuzumab deruxtecan,Palbociclib",Drugs
"CDK4/6 inhibitors, Endocrine therapy",Drugs
"CDK4/6 inhibitors, Aromatase inhibitors",Drugs
Trastuzumab deruxtecan,Drugs
"Camizestrant, Fulvestrant",Drugs
"CDK4/6 inhibitors, anti-HER2",Drugs
"Dalpiciclib, pyrotinib",Drugs
"Tucatinib, letrozole, palbociclib",Drugs
Ribociclib,Drugs
Aromatase inhibitors,Drugs
"trastuzumab, lapatinib, pertuzumab, ado-trastuzumab emtansine",Drugs
Ibrutinib,Drugs
"Tucatinib, Palbociclib, Fulvestrant",Drugs
"Palbociclib, Abemaciclib, Ribociclib",Drugs
"Pertuzumab,T-DM1,Tyrosine kinase inhibitors",Drugs
Tamoxifen,Drugs
Letrozole,Drugs
"Fulvestrant, BKM120",Drugs
"Pemrametostat, Fulvestrant",Drugs
Fulvestrant,Drugs
"Fulvestrant, Camizestrant",Drugs
"LH-RH agonist, aromatase inhibitor",Drugs
Elacestrant,Drugs
Endocrine therapy,Drugs
Hormone therapy,Drugs
ER伪 inhibitors,Drugs
Anti-estrogens,Drugs
"Anti-estrogens, PI3K/AKT/mTOR inhibitors, CDK4/6 inhibitors",Drugs
"elacestrant, fulvestrant",Drugs
ATP-competitive inhibitors,Drugs
GPX4 inhibitors,Drugs
Selective ER degraders,Drugs
"Fulvestrant, aromatase inhibitors",Drugs
"Fulvestrant, anastrozole",Drugs
"SERD, SSH-CDK4/6 inhibitors",Drugs
Antiestrogens,Drugs
fulvestrant,Drugs
"tamoxifen,aromatase inhibitors",Drugs
"H3B-6545, fulvestrant",Drugs
H3B-6545,Drugs
Camizestrant,Drugs
Inhibitors of CDK4 and MDM2,Drugs
"CDK4 inhibitors, MDM2 inhibitors, cediranib, eribulin, crizotinib",Drugs
Bortezomib,Drugs
Anti-MDM2 therapies,Drugs
MDM2 inhibitors,Drugs
"CDK4/6 inhibitors,ET",Drugs
MTOR,Drugs
"Palbociclib, Everolimus",Drugs
"CDK4/6 inhibitors, mTOR inhibitors",Drugs
"Alpelisib, MLN0128, palbociclib",Drugs
Alpelisib,Drugs
nab-sirolimus,Drugs
"PI3K inhibitors, mTOR inhibitors, CDK4/6 inhibitors, Epigenetic modulators",Drugs
"deucravacitinib, CDK4/6 inhibitors, mTOR inhibitors",Drugs
"Everolimus, sunitinib",Drugs
"CDK4/6 inhibitors, mTOR inhibitors, PI3K inhibitors",Drugs
"VEGF inhibitors, mTOR inhibitors",Drugs
MLN0128,Drugs
"Palbociclib, MLN0128",Drugs
mTOR inhibitor,Drugs
Everolimus,Drugs
RMC-6272,Drugs
"PI3K inhibitors, mTOR inhibitors",Drugs
E6201,Drugs
"CDK4/6 inhibitors, PI3K/mTOR inhibitors",Drugs
FMD,Drugs
PIK3CA/mTOR inhibitors,Drugs
"Ribociclib, everolimus",Drugs
mTOR inhibitors,Drugs
"Everolimus,Palbociclib,Ribociclib,Abemaciclib,Alpelisib",Drugs
"PI3K/mTOR inhibitors, fulvestrant",Drugs
"CDK4/6 inhibitors, PI3K/AKT/mTOR inhibitors",Drugs
"Aromatase inhibitors, mTOR inhibitors, CDK4/6 inhibitors",Drugs
"PI3Ki, anti-HER2, chemotherapy, CDK4/6 inhibitors, mTOR inhibitors",Drugs
Gedatolisib,Drugs
"mTOR inhibitors, CDK4/6 inhibitors",Drugs
"CDK4/6 inhibitors,mTOR inhibitors",Drugs
Abiraterone,Drugs
"Olaparib, Palbociclib",Drugs
Doxazosin,Drugs
Olaparib,Drugs
TGF-β,Drugs
"Palbociclib, fulvestrant",Drugs
Cobimetinib,Drugs
"MEK1/2 inhibitors, CDK4/6 inhibitors",Drugs
"Binimetinib, Ribociclib",Drugs
Binimetinib,Drugs
"CDK4/6 inhibitors, MEK inhibitors",Drugs
"PI3K inhibitors, FGFR inhibitors, CDK4/6 inhibitors",Drugs
PI3K inhibitors,Drugs
"PI3K inhibitors, CDK4/6 inhibitors",Drugs
"CDK4/6 inhibitors, FLT3 inhibitors, pan-PI3K inhibitors",Drugs
"Piqray, Fulvestrant",Drugs
"Capivasertib, fulvestrant",Drugs
"KRAS inhibitors, PI3K inhibitors, HSP90 inhibitors, CDK4/6 inhibitors, SHP2 inhibitors",Drugs
"Alpelisib, Ribociclib",Drugs
"Ribociclib, Alpelisib",Drugs
"Palbociclib, 7rh",Drugs
"PI3K inhibitors, HSP90 inhibitors",Drugs
"PIK3CA inhibitors, AR inhibitors, BCL2 inhibitors",Drugs
alpelisib,Drugs
TQB3616,Drugs
abemaciclib,Drugs
"MPT0L145, abemaciclib",Drugs
HMBA,Drugs
CDK inhibitors,Drugs
G1T38,Drugs
Dalpiciclib,Drugs
"PD-0332991, LEE011",Drugs
rapamycin,Drugs
"palbociclib, doxorubicin, AZD1775",Drugs
"ARV-825, Fulvestrant, Palbociclib",Drugs
"Palbociclib, Abemaciclib",Drugs
PF-7006,Drugs
"RP-6306, Gemcitabine",Drugs
Piceatannol,Drugs
doxorubicin,Drugs
"RP-6306, gemcitabine",Drugs
TP53-modulating drugs,Drugs
PI3K,Pathway
"EGFR, HER2, AKT",Pathway
IL-17 signaling,Pathway
"p16(INK4A)-CDK4-RB, RAS-RAF-MEK-ERK, PI3K-AKT",Pathway
RAS-BRAF,Pathway
RAS-RAF-MEK-ERK,Pathway
"BRAF/MEK, ALK, CDK4/6",Pathway
Mitogen-activated protein kinase pathway,Pathway
RAS-MAPK,Pathway
MAPK,Pathway
BRAF pathway,Pathway
p16-cdk4-cyclin D1-pRb,Pathway
CDK4/CDK6-cyclin D1-Rb-p16/ink4a pathway,Pathway
CDK4/CDK6-cyclin D1 pathway,Pathway
Ubiquitin-proteasome system,Pathway
Cell-cycle pathway,Pathway
"PI3K-AKT, CCND1-CDK4/6",Pathway
pRb,Pathway
Cell cycle,Pathway
Cell-cycle markers,Pathway
PI3K/AKT,Pathway
AKT/mTOR,Pathway
G1-phase pathway,Pathway
G1-S transition,Pathway
"MEK, p38, ERK1/2",Pathway
AP-1,Pathway
G1 phase,Pathway
p38 MAPK,Pathway
PI3K/AKT pathway,Pathway
ERK1/2,Pathway
"STAT3,Erk,p38",Pathway
CDK4-cyclin D1 pathway,Pathway
Cell cycle progression,Pathway
G1-S regulatory pathway,Pathway
RAS/MAPK,Pathway
G1/S transition,Pathway
Cyclin D/CDK4,Pathway
Cyclin D1/CDK4,Pathway
Cyclin pathway,Pathway
ER-cyclin D1-CDK4/6-RB pathway,Pathway
Cyclin signaling,Pathway
CDK4/6-cyclin D1,Pathway
"Wnt, Hippo",Pathway
CDKN2A-CCND-CDK4/6-Rb,Pathway
Akt/GSK-3/Cdc2 pathway,Pathway
mTORC1/2,Pathway
"PKC,MAPK",Pathway
G1 arrest,Pathway
"PI3K/AKT/mTOR, Cell-cycle machinery",Pathway
Raf-Mek-Erk pathway,Pathway
Cell cycle pathway,Pathway
FAMMM,Pathway
"RB1,TP53",Pathway
p16INK4/CDK4/RB,Pathway
Cell cycle control,Pathway
"Rb-CDK4,p53",Pathway
Rb pathway,Pathway
"Rb-CDK4, p53 pathways",Pathway
p16INK4a/cyclin D/CDK4/6/RB pathway,Pathway
MEK,Pathway
Cyclin D-CDK4/6-Rb-INK4,Pathway
CDK4/6/RB pathway,Pathway
p53 pathway,Pathway
"CDK4-pRb, p53",Pathway
pRB,Pathway
P16(INK4A)-CDK4/6-RB,Pathway
Pigmentation pathway,Pathway
G1 cyclin-dependent kinase,Pathway
TGFB,Pathway
COX-2/Wnt,Pathway
"p53, p16",Pathway
Rb/p16INK4a/cyclin D-dependent kinase,Pathway
Rb and p53/MDM2/p14ARF,Pathway
RAR signaling,Pathway
Cyclin D-CDK4/6,Pathway
"MAPK, Cell cycle",Pathway
TGF beta,Pathway
TGF-beta,Pathway
"CDK4/6,Erk1/2",Pathway
"mTORC1/2,CDK4/6",Pathway
EGFR,Pathway
EGFR-TKI pathway,Pathway
"MAPK, AKT, STAT3, Src, Abl",Pathway
"p16-CDK4/6-RB,AREG/EGFR",Pathway
"CDK4/6,IGF1R/FGFR/EGFR",Pathway
"EGFR, HER2",Pathway
EGFR signaling,Pathway
PI3K/AKT/mTOR,Pathway
"Estrogen signaling, HER2 signaling",Pathway
PIK3CA/mTOR,Pathway
MAP kinase pathway,Pathway
ATR:CHK1,Pathway
"mTORC1/2,CDK4/6,ER",Pathway
Growth factor receptor signaling,Pathway
Retinoblastoma pathway,Pathway
12q13-15 region,Pathway
TP53 pathway,Pathway
"pRB/CDK4/RB1/P16(ink4),TP53/MDM2/P14(arf),PI3K/Akt-PTEN",Pathway
mTOR,Pathway
MTOR,Pathway
"PI3K/AKT/mTOR, CDK4/6",Pathway
CDK4/6,Pathway
PI3K/Akt/mTOR,Pathway
"PI3K/Akt/mTOR,CDK4/6/RB",Pathway
PI3K/mTOR,Pathway
PI3K/AKT/mTOR signaling pathway,Pathway
"MAPK, mTORC1/p70S6K, src/FAK",Pathway
mTOR/p70-S6k,Pathway
"PI3K/AKT, PTEN, mTOR",Pathway
PI3K-mTOR,Pathway
mTORC1,Pathway
"Metabolic pathway, ROS signaling pathway, HIF1a, mTOR signaling",Pathway
"PI3K-AKT, mTOR, CDK4/6",Pathway
"MTORC1, E2F, MYC",Pathway
"PI3K/mTOR, CDK4/6",Pathway
"PI3K, AKT, mTOR",Pathway
AKT/mTOR axis,Pathway
AKT/mTOR pathway,Pathway
"PI3K-mTOR pathway,RAS/RAF/MAPK pathway",Pathway
Amplifications,Pathway
HR,Pathway
JNK/CDK4-dependent pSmad3L,Pathway
Endocrine signaling,Pathway
Beta-catenin-Tcf,Pathway
Wnt signaling,Pathway
"MAPK, PI3K, CDK4/6",Pathway
Senescence escape,Pathway
PI3K pathway,Pathway
PIK3CA-AKT,Pathway
"PI3K, AKT",Pathway
PI3K-AKT,Pathway
"PI3K, Cell-cycle, Apoptosis",Pathway
"MAPK, PI3K, S6K1",Pathway
"Notch, PI3K/AKT",Pathway
"MAPK, AKT",Pathway
mTOR pathway,Pathway
S6K1,Pathway
DNA repair pathway,Pathway
PTEN-related pathways,Pathway
PI3K-PTEN-AKT-FoxO3a,Pathway
Rb1,Pathway
G1-S checkpoint,Pathway
CDK4/6-RB,Pathway
c-Myc,Pathway
NF-魏B,Pathway
"NF-魏B, AKT",Pathway
Cyclin D-CDK4/6-INK4-Rb,Pathway
G1 control pathway,Pathway
pRb pathway,Pathway
CDK4/6-RB pathway,Pathway
Cyclin D1-CDK4/6-retinoblastoma pathway,Pathway
Cyclin D-CDK4/6-Rb pathway,Pathway
CDK-Rb-E2F,Pathway
"MAPK, Akt",Pathway
CDK4/6-Rb-E2F pathway,Pathway
Cyclin D-CDK4/6-Rb,Pathway
CKI-CDK-Rb pathway,Pathway
"p53 control, growth signaling, cell cycle control",Pathway
"Hedgehog, Akt, p53",Pathway
NOTCH,Pathway
DNA damage response,Pathway
ARF-p53,Pathway
